Addus HomeCare Corporation

NASDAQ:ADUS

Medical - Care Facilities

Healthcare
$120.85 +0.31%

+$0.29 today

Market cap
$2.25B
Beta
0.90
P/E (TTM)
17.4
EPS (TTM)
$5.40
52W Low $87.95High $124.44

Volume 0.23M

Average 0.25M

ADUS EBITDA Margin

EBITDA as a percentage of revenue.

Addus HomeCare CorporationNASDAQ: ADUS

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin widens to 11.6%

EBITDA Margin was 11.6% in Q2 FY2026, up 0.9 pp from a year earlier. On a trailing-twelve-month basis it was 11.3%, up 0.7 pp year over year. Over 3 fiscal years it widened by 2.0 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 9 analysts of 13.0% for the fiscal year ending Dec 2026, up from 10.8% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
11.6%+0.9 pp QoQ
Last fiscal yearDec 2025
10.8%+0.3 pp YoY
LTMJun 2026
11.3%+0.7 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.9 pp+2.1 pp+1.2 pp
1 year+0.3 pp+2.2 pp+1.9 pp
3 years+2.0 pp+2.1 pp+0.0 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
10.8%
Year-over-year change
+0.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How ADUS compares with its peers on the latest reported figures

  • ADUS's LTM Jun 2026 EBITDA Margin of 11.3% is the 5th highest of the 7 companies compared; the peer median is 13.1%.
  • Its year-over-year change of +0.7 pp is the 3rd highest of 7, against a peer median of +0.2 pp.
  • Over three fiscal years its change of +2.0 pp compares with a peer median of +3.2 pp.
ADUS Competitors Peer median
EBITDA Margin for ADUS and competitors
Company Period LTM level YoY 3-year change
EHCEncompass Health CorporationLTM Jun 202624.2% +1.1 pp+3.6 pp
CHEChemed CorporationLTM Jun 202616.6% -1.4 pp-1.7 pp
NHCNational HealthCare CorporationLTM Sep 202613.1% +0.5 pp+7.7 pp
AVAHAveanna Healthcare Holdings Inc.LTM Oct 202613.0% +1.4 pp+40.8 pp
ADUSAddus HomeCare CorporationLTM Jun 202611.3% +0.7 pp+2.0 pp
ENSGThe Ensign Group, Inc.LTM Jun 202611.3% -0.1 pp-0.7 pp
PNTGThe Pennant Group, Inc.LTM Mar 20265.9% -0.7 pp+2.7 pp
Peer median (excluding ADUS) 13.1%+0.2 pp+3.2 pp

Competitors are the stored peer set for ADUS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue864.5M951.12M1.06B1.15B1.42B
Cost of Revenue595.24M651.38M718.78M779.58M960.66M
Gross Profit269.85M299.74M339.88M375.02M461.87M
Gross Margin31.2%31.5%32.1%32.5%32.5%
Research & Development00000
Selling, General & Admin189.42M216.94M231.68M258.8M306.85M
Operating Expenses203.32M231M248.92M272.33M323.26M
Depreciation & Amortization14.49M14.06M14.13M13.53M16.41M
EBITDA80.7M83.14M106.56M120.62M153.44M
EBITDA Margin9.3%8.7%10.1%10.4%10.8%
Operating Income65.94M68.74M90.96M102.69M138.62M
Operating Margin7.6%7.2%8.6%8.9%9.7%
Interest Income268K341K1.48M4.39M1.59M
Interest Expense5.81M8.91M11.11M7.73M9.58M
Other Income / Expenses(5.54M)(8.57M)(9.63M)(3.34M)(11.17M)
Income Before Tax60.4M60.17M81.33M99.35M127.45M
Pre-Tax Margin7.0%6.3%7.7%8.6%9.0%
Income Tax Expense15.27M14.15M18.81M25.76M31.54M
Net Income45.13M46.03M62.52M73.6M95.91M
Net Margin5.2%4.8%5.9%6.4%6.7%
EPS (Basic)2.872.903.914.335.19
EPS (Diluted)2.812.843.834.235.21
Weighted Avg Shares15.74M16.13M16.23M17.01M18.45M
Weighted Avg Shares (Diluted)16.06M16.18M16.31M17.38M18.45M

Addus HomeCare Corporation

NASDAQ:ADUS

Intrinsic Alpha fair value

Locked

Current Price

$120.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.